Collegium Pharmaceutical (COLL) Gross Margin (2016 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Gross Margin of 60.59% for Q1 2026, up 583.0% year-over-year from 8.87% in Q1 2025, and down 3.04% quarter-over-quarter from 62.49% in Q4 2025.
Collegium Pharmaceutical (COLL) Gross Margin (2016 - 2026) Analysis & Trends
Collegium Pharmaceutical's Gross Margin history runs 11 years deep, the most recent figure standing at 60.59% for Q1 2026.
- In Q1 2026, Gross Margin rose 583.0% year-over-year to 60.59%; the TTM figure through Mar 2026 stood at 60.68% (down 1308.0% YoY), while the FY2025 annual figure was 59.35%, down 41.0% from the prior year.
- Gross Margin for Q1 2026 stood at 60.59%, down from 62.49% in the prior quarter.
- The five-year high for Gross Margin was 263.94% in Q4 2024, with the low at 35.4% in Q4 2022.
- The 5-year median for Gross Margin is 58.75% (2023), against an average of 68.2%.
- The sharpest annual moves came in 2024 and 2025: Gross Margin surged 20074 bps in 2024, then tumbled 20145 bps in 2025.
- Collegium Pharmaceutical's Gross Margin stood at 35.4% in 2022, then jumped by 79 bps to 63.19% in 2023, then soared by 318 bps to 263.94% in 2024, then plunged by 76 bps to 62.49% in 2025, then fell by 3 bps to 60.59% in 2026.
- Business Quant data shows COLL's Gross Margin at 60.59% in Q1 2026, 62.49% in Q4 2025, and 61.7% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Collegium Pharmaceutical | 889.49 Mn | 740.17 Mn | 110.29 Mn | 55.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 854.31% |
| Mar 31, 2026 | 60.59% |
| Dec 31, 2025 | 62.49% |
| Sep 30, 2025 | 61.70% |
| Jun 30, 2025 | 57.65% |
| Mar 31, 2025 | 54.75% |
| Dec 31, 2024 | 263.94% |
| Sep 30, 2024 | 60.76% |
| Jun 30, 2024 | 62.51% |
| Mar 31, 2024 | 63.11% |
| Dec 31, 2023 | 63.19% |
| Sep 30, 2023 | 58.75% |
| Jun 30, 2023 | 54.47% |
| Mar 31, 2023 | 53.47% |
| Dec 31, 2022 | 35.40% |
| Sep 30, 2022 | 46.33% |
| Jun 30, 2022 | 42.38% |
| Mar 31, 2022 | 57.90% |
| Dec 31, 2021 | -3.48% |
| Sep 30, 2021 | 58.49% |